Clinical Trial Psych Rater - Czech SpeakingVerified as a real position
IQVIA
Czechia, Prague13 days ago
- Posted
- Employment type
- Part-time
Salary range
Unlock the AI salary estimate
See the salary estimate and how this position stands in the market.
Klinický výzkumSeniorPANSS / CGI-SČeština + angličtinaRemotePart-time
Get more replies from employers
Send the employer a tailored CV in minutes.
Who we’re looking for
- Education: Master’s degree (MA/MS) in Psychology, Counseling, Psychiatric Nursing, or Social Work (or equivalent). MD, DO, or PhD preferred.
- Experience: Minimum 3 years administering psychiatric assessments, rating scales, and/or structured clinical interviews (specifically PANSS, CGI-S).
- Minimum 3 years of clinical experience with psychiatric populations.
- Minimum 3 years administering scales in clinical research trials (excluding graduate/doctoral research).
- Experience in CNS trials preferred.
- Language Requirement Current openings require fluency in English and native-level proficiency in Czech.
What you’ll do
- Participate in all required orientation, training, and calibration activities.
- Review case data and prepare for rater discussions, ensuring all relevant documents and scale items are available.
- Conduct live interactions with raters to provide feedback and guidance on assessment methodology and scoring.
- Complete assigned tasks and rater interactions according to schedule.
- Submit all required documentation accurately and on time.
About the position
Clinical Trial Psych Rater - Czech Speaking Location: Remote/Virtual Hours: Estimated 10–16 hours per month Role: Clinical Specialist About IQVIA IQVIA is a global leader in advanced analytics, technology solutions, and clinical research services, dedicated to driving healthcare forward. We partner with the world’s leading pharmaceutical, biotechnology, and medical device companies to improve patient outcomes and accelerate innovation. Our team combines deep scientific expertise with cutting-edge technology to deliver high-quality data and insights that shape the future of clinical trials.